Information in English
The Swedish Act Biobanks in Medical Care (SFS 2002:297) allows that human biological specimens that have been collected and/or stored with the purpose healthcare may be used both for research purposes and clinical trials if the patients/donor have given consent to this. Collection and/or use of human samples for research purposes require approval by a Swedish Ethics Review Board for each specific project/clinical trial, and the application must be submitted by a Swedish research principal. Furthermore, clinical trials for medical products must be approved by the Swedish Medical Products Agency.
Given these preconditions, an application for access to samples from a biobank can be submitted either to
1) the head/custodian of a biobank (‘Biobanksansvarig’). For further information, see below.
2) a regional biobank centre, (‘Regionalt Biobankscentrum’). This is preferred for research where more than one helthcare biobank provides samples, and when the samples are newly collected for that specific research project and are to be released to a recipient research biobank. This procedure is named the multicentre principle. For further information about the multicentre principle, see below.
1) Access to samples for research
Information and applications for research where the application is submitted to the custodian of a biobank. For contact information about specific biobanks, please contact the biobank coordinators (‘Biobankssamordnare’).
This procedure is used in studies
– with only one responsible sample collecting body or biobank (single-centre studies)
– based on existing samples (single-centre or multi-centre studies)
– when samples are not be released, but only accessed
2) Access to samples for research according to the multicentre principle
Information and applications for research where the application is submitted to a Regional Biobank Centre (RBC) according to the multicentre principle. For contact information click on the links RBC’s respectively e-biobanks.
This procedure is used in studies with more than one responsible sample collecting body or biobank (multi-centre studies), where the samples are
– newly collected, and
– shall be released to a recipient biobank